Jacquie Liggett Fellowship
| Nadim Bou Zgheib, M.D. | 2011-2012 Fourth Fellow |
H.O.W. Fellowship, Moffitt Cancer Center, University of South Florida, Tampa
Resident in Obstetrics and Gynecology, St. Lukes Hospital and Health Network, Bethlehem, PA; American University of Beirut; Lebanon, Memorial Sloan Kettering Cancer Institute, New York, NY
Board Member of the Up the Volume Foundation
MD, Lebanese University
The fourth fellow selected, Dr. Zgheib, along with doctors Mitchel Hoffman and Johnathan Lancaster will study a genetic pathway that causes ovarian cancer cells to stop responding to chemotherapy. If researchers can understand teh genetic changes that cause cancers to become chemo-resistant, they may be able to develop drugs to reverse teh process and prolong survival.
The Jacquie Liggett Fellowship for research is awarded to a qualified MD or PhD conducting research in the field of ovarian cancer. The Fellow receives a stipend of $50,000 a year for two years, and an additional third year can be approved depending on the quality and accomplishments of the research. Past award recipients have been researchers (experts in ovarian cancer) from the Moffitt Cancer Center at the University of South Florida in Tampa.
| Douglas C. Marchion, Ph.D. | 2008-2010 Third Fellow |
Research Scientist, Moffitt Cancer Center, University of South Florida, Tampa
Postdoctoral Research Fellowship, Moffitt Cancer Center
PhD, University of Montana
The third fellow selected, Dr. Marchion has considerable experience in translational research in women’s oncology. With the support of the Liggett Fellowship, Dr. Marchion will lead a potentially land-mark ovarian cancer project. The overall goal of his research will be to characterize the unifocal versus multifocal nature of advanced-stage ovarian carcinoma.
| Robert Wenham, M.D., MSc | 2006-2007 Second Fellow |
Assistant Professor, Moffitt Cancer Center, University of South Florida, Tampa
Fellowship in Gynecologic Oncology, Duke University
Resident in Obstetrics and Gynecology, Brigham & Women’s Hospital, Harvard Medical School
MD, MSc, University of Texas Southwestern Medical School
The second fellow selected, Dr. Wenham began his fellowship in July of 2006. He is investigating novel therapeutics and drug combinations that will overcome chemotherapy resistance. Dr. Wenham is a co-investigator of a clinical trial to treat patients with advanced or recurrent ovarian cancer utilizing methods to enhance the standard chemotherapy for ovarian cancer.
| Johnathan M. Lancaster, M.D., Ph.D. | 2003-2005 First Fellow |
Associate Professor, Moffitt Cancer Center, University of South Florida, Tampa
Division Chief, Gynecologic Surgical Oncology
Medical Director, Lifetime Cancer Screening & Prevention Center
Fellowship in Gynecologic Oncology, Duke University
Resident in Obstetric & Gynecology, Cambridge University, U.K.
MD University of Wales, U.K.
PhD University of Wales, U.K.
Awarded the first Jacquie Liggett Fellowship beginning in July 2003. Dr. Lancaster is investigating the molecular genetic causes of ovarian cancer development, progression and response to therapy. This research will enable physicians to direct more specific chemotherapeutic interventions for ovarian cancer. The H.O.W. Medical Advisory Board awarded him an additional year of support because of his excellent research.